← Leaderboards
Henry F Chambers
Duke University
$93,384,193
Attributed
$178,622,635
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $20.4M · FY2007–25$25M$18.8M$12.5M$6.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$178,622,635 · 11
By mechanism
UM1$166,501,529 · 1
R01$7,426,384 · 3
T32$3,093,016 · 1
R56$1,078,112 · 1
U19$444,329 · 1
R03$73,750 · 1
Top collaborators
- Vance G Fowler14 shared
- Som Chatterjee7 shared
- Binh An Diep1 shared
Others in their field
Top investigators on “Bacteria”
- James E. Gern · University Of Wisconsin-Madison$138,333,846
- Ian A Wilson · Scripps Research Institute, The$90,122,969
- Vance G Fowler · Duke University$85,101,521
- Timothy Henkel · Venatorx Pharmaceuticals, Inc.$48,397,895
- David Alland · Rutgers Biomedical And Health Sciences$47,292,355
- Peter D Karp · Sri International$46,333,879
Research focus
BacteriaLeadGene ExpressionClinical ResearchStaphylococcus AureusResistanceClinical TrialsPhenotypePenicillinsDesignBiologyBasePathogenCommunitiesAntibioticsProductionProteinsBeta-Lactam ResistanceMutationData ManagementFundamental ResearchComplexData AnalysesEvaluation
Grant awards (56)
Antibacterial Resistance Leadership Group (ARLG)$14,396,446
UM1 · FY2025 · AI
Antibacterial Resistance Leadership Group (ARLG)$14,519,432
UM1 · FY2024 · AI
Antibacterial Resistance Leadership Group (ARLG)$14,675,641
UM1 · FY2023 · AI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$653,716
R01 · FY2023 · AI
Antibacterial Resistance Leadership Group (ARLG)$14,729,883
UM1 · FY2022 · AI
Antibacterial Resistance Leadership Group (ARLG)$19,709,872
UM1 · FY2021 · AI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$653,716
R01 · FY2021 · AI
Antibacterial Resistance Leadership Group (ARLG)$14,943,650
UM1 · FY2020 · AI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$653,763
R01 · FY2020 · AI
Antibacterial Resistance Leadership Group (ARLG)$56,350
UM1 · FY2020 · AI
Antibacterial Resistance Leadership Group (ARLG)$19,183,975
UM1 · FY2019 · AI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$583,027
R01 · FY2019 · AI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$121,881
R01 · FY2019 · AI
Antibacterial Resistance Leadership Group (ARLG)$10,000,000
UM1 · FY2018 · AI
RESEARCH PROJECT 2$444,329
U19 · FY2018 · AI · contact PI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$231,141
R01 · FY2018 · AI
Antibacterial Resistance Leadership Group (ARLG)$8,000,000
UM1 · FY2017 · AI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$686,758
R56 · FY2017 · AI · contact PI
Biology of Infectious Diseases Training Program$287,254
T32 · FY2017 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$10,000,000
UM1 · FY2016 · AI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$587,186
R01 · FY2016 · AI · contact PI
Biology of Infectious Diseases Training Program$213,266
T32 · FY2016 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$11,286,280
UM1 · FY2015 · AI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$711,152
R01 · FY2015 · AI · contact PI
Biology of Infectious Diseases Training Program$220,932
T32 · FY2015 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$13,000,000
UM1 · FY2014 · AI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$672,580
R01 · FY2014 · AI · contact PI
Biology of Infectious Diseases Training Program$211,335
T32 · FY2014 · AI · contact PI
Antibacterial Resistance Leadership Group (ARLG)$2,000,000
UM1 · FY2013 · AI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$277,961
R01 · FY2013 · AI · contact PI
Biology of Infectious Diseases Training Program$230,466
T32 · FY2013 · AI · contact PI
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus$391,354
R56 · FY2012 · AI · contact PI
Biology of Infectious Diseases Training Program$229,911
T32 · FY2012 · AI · contact PI
Biology of Infectious Diseases Training Program$207,088
T32 · FY2011 · AI · contact PI
Genetic Basis of Virulence of Community MRSA Clone USA300$382,388
R01 · FY2010 · AI · contact PI
Biology of Infectious Diseases Training Program$244,478
T32 · FY2010 · AI · contact PI
Genetic Basis of Virulence of Community MRSA Clone USA300$386,250
R01 · FY2009 · AI · contact PI
Biology of Infectious Diseases Training Program$243,467
T32 · FY2009 · AI · contact PI
Genetic Basis of Virulence of Community MRSA Clone USA300$382,675
R01 · FY2008 · AI · contact PI
Biology of Infectious Diseases Training Program$241,471
T32 · FY2008 · AI · contact PI
Biology of Infectious Diseases Training Program$241,471
T32 · FY2007 · AI · contact PI
BIOLOGY OF INFECTIOUS DISEASES TRAINING PROGRAM$266,765
T32 · FY2004 · AI
Daptomycin therapy for serious staphylococcus aureus infection$951
M01 · FY2004 · RR
PENICILLIN INTERACTIVE PROTEINS OF STAPHYLOCOCCUS AUREUS$274,680
R01 · FY2003 · AI
BIOLOGY OF INFECTIOUS DISEASES TRAINING PROGRAM$255,112
T32 · FY2003 · AI
PENICILLIN INTERACTIVE PROTEINS OF STAPHYLOCOCCUS AUREUS$282,964
R01 · FY2002 · AI
SALVAGE THERAPY FOR MULTI DRUG RESISTANT TUBERCULOSIS$0
M01 · FY2002 · RR
SALVAGE THERAPY FOR MULTI DRUG RESISTANT TUBERCULOSIS$0
M01 · FY2002 · RR
PENICILLIN INTERACTIVE PROTEINS OF STAPHYLOCOCCUS AUREUS$312,302
R01 · FY2001 · AI
Gordon Research Conference on Staphylococcal Diseases$4,000
R13 · FY2001 · AI
SALVAGE THERAPY FOR MULTI DRUG RESISTANT TUBERCULOSIS$0
M01 · FY2001 · RR
PENICILLIN INTERACTIVE PROTEINS OF STAPHYLOCOCCUS AUREUS$259,002
R01 · FY2000 · AI
VANCOMYCIN-RESISTANT STAPHYLOCOCCUS AUREUS$73,750
R03 · FY2000 · AI
SALVAGE THERAPY FOR MULTI DRUG RESISTANT TUBERCULOSIS$564
M01 · FY2000 · RR
SALVAGE THERAPY FOR MULTI DRUG RESISTANT TUBERCULOSIS$0
M01 · FY2000 · RR
SALVAGE THERAPY FOR MULTI DRUG RESISTANT TUBERCULOSIS$0
M01 · FY2000 · RR